Your Article Summary
See Latest ArticlesMoving toward new statin guidelines in a post-JUPITER world: Principles to consider
Current Atherosclerosis Reports, 06/22/09
Ridker PM - Absolute risk reductions within JUPITER result in a number needed to treat at 5 years of 25, a value comparable or superior to that of other interventions routinely used in primary prevention, including statin therapy among those with hyperlipidemia. Although lifestyle interventions remain critical, the screening and treatment strategy tested in JUPITER is likely to impact on new guidelines for cardiovascular disease prevention.
Related Articles
CRESTOR reduced risk of cardiovascular events in women by nearly half in new analysis of JUPITER study
AstraZeneca, 11/18/09
Relevance Score: 84%
Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA
Expert Review of Cardiovascular Therapy, 11/16/09
Relevance Score: 80%
Treating cholesterol: Drugs and natural options
Internet Source, 10/09/09
Relevance Score: 80%
Today in Prevention...keeping you current
Receive free subspecialty "5-minute updates" via email
Distribution and Cardiovascular Risk Correlates of Plasma Soluble Intercellular Adhesion Molecule-1 Levels in Asymptomatic Young Adults from a Biracial Community: The Bogalusa Heart Study
Annals of Epidemiology , 12/15/09
Functional foods for dyslipidaemia and cardiovascular risk prevention
Nutrition Research Reviews, 12/15/09
Physical Exercise Prevents Cellular Senescence in Circulating Leukocytes and in the Vessel Wall
Circulation, 12/15/09